GoodRx Expands Access to Eli Lilly's Zepbound KwikPen-March 2024-www.financetom.com

GoodRx Expands Access to Eli Lilly's Zepbound KwikPen

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GoodRx Expands Access to Eli Lilly's Zepbound KwikPen

Mar 11, 2026 6:53 AM

09:44 AM EST, 03/06/2026 (MT Newswires) -- GoodRx ( GDRX ) said Friday it is collaborating with Eli Lilly ( LLY ) to expand employer-sponsored access to the obesity treatment Zepbound KwikPen through GoodRx Employer Direct.

The company said self-insured employers will be able to access the medication at $449 across all doses, with the option to further subsidize the cost for employees at the pharmacy counter.

Price: 2.27, Change: -0.02, Percent Change: -0.87

Previous page： Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition Next page： Sanofi wins US approval for drug combination to treat multiple myeloma

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition

Sep 21, 2024

03:56 PM EDT, 09/20/2024 (MT Newswires) -- Blank-check firm FutureTech II Acquisition ( FTII ) agreed to a merger agreement earlier this week and take Longevity Biomedical public, the companies said Friday. The combined company will operate as Longevity Biomedical and is expected to list on Nasdaq under the LBIO ticker, the companies said. The new company will have approximately...

Sanofi wins US approval for drug combination to treat multiple myeloma

Sep 21, 2024

Sept 20 - Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been used only after standard treatments have failed, the U.S. Food and Drug Administration said on Friday. ...

Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing

Sep 21, 2024

04:08 PM EDT, 09/20/2024 (MT Newswires) -- Edward Stewart, Director, on September 20, 2024, sold 2,800 shares in Rbc Bearings ( RBC ) for $837,202. Following the Form 4 filing with the SEC, Stewart has control over a total of 20,461 shares of the company, with 20,461 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324948/000159396824001214/xslF345X05/primary_01.xml Price: 295.45, Change: +0.11, Percent Change: +0.04...

Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing

Sep 21, 2024

04:09 PM EDT, 09/20/2024 (MT Newswires) -- Charles Dutil, Director, on September 18, 2024, sold 12,500 shares in Rev Group ( REVG ) for $356,250. Following the Form 4 filing with the SEC, Dutil has control over a total of 41,628 shares of the company, with 41,628 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1687221/000095010324013803/xslF345X05/dp218237_4.xml Price: 27.61, Change: -0.01, Percent Change: -0.04...